Sopharma AD (WSE: SPH)

Market Cap	2.07B
Revenue (ttm)	4.50B
Net Income (ttm)	179.38M
Shares Out	n/a
EPS (ttm)	1.01
PE Ratio	11.53
Forward PE	n/a
Dividend	0.36 (2.90%)
Ex-Dividend Date	Nov 7, 2024

Volume	271
Average Volume	63
Open	13.20
Previous Close	12.50
Day's Range	13.20 - 13.55
52-Week Range	11.40 - 15.70
Beta	-0.04
RSI	58.02
Earnings Date	Jan 30, 2025

About Sopharma AD

Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally. The company operates through Production of Pharmaceutical Products; Distribution of Pharmaceutical Products (Goods); and Others. It offers Carsil to treat liver disease; Tempalgin and Analgin, a painkiller; Tabex, drug used for smoking secession; Tribestan, drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin, used for diseases of the peripheral nervous system; Methylpredni...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1933
• Employees: 4,721
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: SPH

Financial Performance

In 2023, Sopharma AD's revenue was 1.89 billion, an increase of 12.95% compared to the previous year's 1.67 billion. Earnings were 95.21 million, an increase of 33.87%.

Financial numbers in BGN